The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents
Abstract
Toll-like receptor (TLR) agonists are being developed for use as vaccine adjuvants and as stand-alone immunomodulators because of their ability to stimulate innate and adaptive immune responses. Among the most thoroughly studied TLR agonists are the lipid A molecules that target the TLR4 complex. One promising candidate, monophosphoryl lipid A, which is a derivative of lipid A from Salmonella minnesota, has proven to be safe and effective as a vaccine adjuvant in > 120,000 human doses. A new class of synthetic lipid A mimetics, the aminoalkyl glucosaminide 4-phosphates (AGPs), have been engineered specifically to target human TLR4 and are showing promise as vaccine adjuvants and as monotherapeutic agents capable of eliciting nonspecific protection against a wide range of infectious pathogens. In this review, the authors provide an update of the preclinical and clinical experiences with the TLR4 agonists, MPL (Corixa Corporation) adjuvant and the AGPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Takeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,461
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,076
Chanock, R. M., Kim, H. W., Brandt, C., & Parrott, R. H. (1976) · Viral Infections of Humans · doi:10.1007/978-1-4613-3988-5_17 · Cited by 1,085
Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria
Ayabe, T., Satchell, D. P., Wilson, C. L., Parks, W. C., Selsted, M. E., & Ouellette, A. J. (2000) · Nature Immunology · doi:10.1038/77783 · Cited by 1,060
A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria
Zhang, D., Zhang, G., Hayden, M. S., Greenblatt, M. B., Bussey, C., Flavell, R. A., & Ghosh, S. (2004) · Science · doi:10.1126/science.1094351 · Cited by 1,004
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870 · cited 1×
“Malaria MPL + QS21 oil-in-water emulsion (SBAS-2) Resistance to parasitaemia [54]”
BackgroundTLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages
Toshchakov, V., Jones, B. W., Perera, P.-Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R. G., Major, J., Hamilton, T. A., Fenton, M. J., et al. (2002) · Nature Immunology · doi:10.1038/ni774 · Cited by 803
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011915 · Cited by 794
Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4984 · Cited by 725
Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells
Re, F., & Strominger, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105927200 · Cited by 691
Hirschfeld, M., Weis, J. J., Toshchakov, V., Salkowski, C. A., Cody, M. J., Ward, D. C., Qureshi, N., Michalek, S. M., & Vogel, S. N. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1477-1482.2001 · Cited by 655
Akira, S. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00013-4 · Cited by 584
Rohde, G. (2003) · Thorax · doi:10.1136/thorax.58.1.37 · Cited by 524
Activation of Autoreactive B Cells by CpG dsDNA
Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J., & Marshak-Rothstein, A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00323-6 · Cited by 521
Toll-like receptors as adjuvant receptors
Kaisho, T., & Akira, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00182-3 · Cited by 492
Corey, L., Langenberg, A. G. M., Ashley, R., Sekulovich, R. E., Izu, A. E., Douglas, Jr., Handsfield, H. H., Warren, T., Marr, L., Tyring, S., et al. (1999) · JAMA · doi:10.1001/jama.282.4.331 · Cited by 490
Lipopolysaccharides from Distinct Pathogens Induce Different Classes of Immune Responses In Vivo
Pulendran, B., Kumar, P., Cutler, C. W., Mohamadzadeh, M., Van Dyke, T., & Banchereau, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5067 · Cited by 483
The role of chemokines in linking innate and adaptive immunity
Luster, A. D. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00308-9 · Cited by 474
Ito, T., Amakawa, R., Kaisho, T., Hemmi, H., Tajima, K., Uehira, K., Ozaki, Y., Tomizawa, H., Akira, S., & Fukuhara, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020207 · Cited by 466
Redecke, V., Häcker, H., Datta, S. K., Fermin, A., Pitha, P. M., Broide, D. H., & Raz, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2739 · Cited by 448
Poltorak, A., Ricciardi-Castagnoli, P., Citterio, S., & Beutler, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040565397 · Cited by 429
Cytokines as a link between innate and adaptive antitumor immunity
Belardelli, F. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02195-6 · Cited by 322
Monophosphoryl lipid A as an adjuvant. Past experiences and new directions.
Ulrich, J. T., & Myers, K. R. (1995) · PubMed · Cited by 301
Drachenberg, K. J., Wheeler, A. W., Stuebner, P., & Horak, F. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.056006498.x · Cited by 285
Mothes, N., Heinzkill, M., Drachenberg, K. J., Sperr, W. R., Krauth, M. T., Majlesi, Y., Semper, H., Valent, P., Niederberger, V., Kraft, D., et al. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01699.x · Cited by 269
Culley, F. J., Pollott, J., & Openshaw, P. J. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020943 · Cited by 259
Taking toll: lipid A mimetics as adjuvants and immunomodulators
Persing, D. H., Coler, R. N., Lacy, M. J., Johnson, D. A., Baldridge, J. R., Hershberg, R. M., & Reed, S. G. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02426-5 · Cited by 258
Self-citationEnhancement of antigen-specific immunity via the TLR4 ligands MPL™ adjuvant and Ribi.529
Evans, J. T., Cluff, C. W., Johnson, D. A., Lacy, M. J., Persing, D. H., & Baldridge, J. R. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.219 · Cited by 243
Self-citationMonophosphoryl Lipid A as an Adjuvant: Past Experiences and New Directions
Ulrich, J. T., & Myers, K. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_21 · Cited by 222
Sosman, J. A., Unger, J. M., Liu, P.-Y., Flaherty, L. E., Park, M. S., Kempf, R. A., Thompson, J. A., Terasaki, P. I., & Sondak, V. K. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.072 · Cited by 205
Monophosphoryl Lipid A Activates Both Human Dendritic Cells and T Cells
Ismaili, J., Rennesson, J., Aksoy, E., Vekemans, J., Vincart, B., Amraoui, Z., Van Laethem, F., Goldman, M., & Dubois, P. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.926 · Cited by 183
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells
De Becker, G., Moulin, V., Pajak, B., Bruck, C., Francotte, M., Thiriart, C., Urbain, J., & Moser, M. (2000) · International Immunology · doi:10.1093/intimm/12.6.807 · Cited by 182
Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists
Stöver, A. G., Correia, J. D. S., Evans, J. T., Cluff, C. W., Elliott, M. W., Jeffery, E. W., Johnson, D. A., Lacy, M. J., Baldridge, J. R., Probst, P., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310760200 · Cited by 162
Self-citationSafety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
Thoelen, S., Damme, P. V., Matheï, C., Leroux-Roels, G. G., Desombere, I., Safary, A., Vandepapelière, P., Slaoui, M., & Meheus, A. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00254-5 · Cited by 156
Baldridge, J., Yorgensen, Y., Ward, J. R., & Ulrich, J. T. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00572-1 · Cited by 137
Self-citationHuman β‐defensins and toll‐like receptors in the upper airway
Claeys, S., Belder, T. D., Holtappels, G., Gevaert, P., Verhasselt, B., Cauwenberge, P. V., & Bachert, C. (2003) · Allergy · doi:10.1034/j.1398-9995.2003.00180.x · Cited by 133
Jotwani, R., Pulendran, B., Agrawal, S., & Cutler, C. W. (2003) · European Journal of Immunology · doi:10.1002/eji.200324392 · Cited by 112
A prophylactic hepatitis B vaccine with a novel adjuvant system
Thoelen, S., Clercq, N. D., & Tornieporth, N. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00462-x · Cited by 71
Endotoxin opens the Toll gates to innate immunity
Ulevitch, R. J. (1999) · Nature Medicine · doi:10.1038/5504 · Cited by 70
Johnson, D. A., Sowell, C. G., Johnson, C. L., Livesay, M. T., Keegan, D. S., Rhodes, M. J., Ulrich, J. T., Ward, J. R., Cantrell, J. L., & Brookshire, V. G. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00374-1 · Cited by 67
Self-citationSacher, T., Knolle, P. A., Nichterlein, T., Arnold, B., H�mmerling, G. J., & Limmer, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200212)32:12<3628::aid-immu3628>3.0.co;2-e · Cited by 67
Vernacchio, L., Bernstein, H. H., Pelton, S., Allen, C., MacDonald, K., Dunn, J., Duncan, D. D., Tsao, G., LaPosta, V., Eldridge, J. H., et al. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00413-9 · Cited by 63
Peptides as requirement for immunotherapy of the guinea-pig line-10 tumor with endotoxins
Ribi, E. E., Parker, R., Strain, S. M., Mizuno, Y., Nowotny, A., Eschen, K. B. V., Cantrell, J. L., McLaughlin, C. A., Hwang, K. M., & Goren, M. B. (1979) · Cancer Immunology Immunotherapy · doi:10.1007/bf00205409 · Cited by 61
Baldridge, J. R., Cluff, C. W., Evans, J. T., Lacy, M. J., Stephens, J. R., Brookshire, V. G., Wang, R., Ward, J. R., Yorgensen, Y. M., Persing, D. H., et al. (2002) · Journal of Endotoxin Research · doi:10.1177/09680519020080061501 · Cited by 50
Self-citationAluminum Is Put on Trial as a Vaccine Booster
Malakoff, D. A. (2000) · Science · doi:10.1126/science.288.5470.1323 · Cited by 31
The Effect of Endotoxin on Resistance to Infection and Disease
Berger, F. M. (1967) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60653-5 · Cited by 27
Cited by
Lipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 896
Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901474 · Cited by 758
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
Casella, C. R., & Mitchell, T. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8228-6 · Cited by 560
Metadata
- Authors
- Baldridge, J. R., McGowan, P., Evans, J. T., Cluff, C., Mossman, S., Johnson, D., & Persing, D.
- Venue
- Expert Opinion on Biological Therapy
- Publisher
- Informa Healthcare
- Published
- 2004-07
- Volume
- 4
- Issue
- 7
- Pages
- 1129-1138
- ISSN
- 1471-2598 (ISSN-L)
- 1744-7682
- OpenAlex
- W2158614517
- Cited by
- 256
- References
- 47
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.